Literature DB >> 35220501

ASO Author Reflections: Reconsidering Resection for Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.

Sarah R Kaslow1, Camilo Correa-Gallego2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35220501     DOI： 10.1245/s10434-022-11479-3

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  The North American Neuroendocrine Tumor Society Consensus Paper on the Surgical Management of Pancreatic Neuroendocrine Tumors.

Authors:  James R Howe; Nipun B Merchant; Claudius Conrad; Xavier M Keutgen; Julie Hallet; Jeffrey A Drebin; Rebecca M Minter; Terry C Lairmore; Jennifer F Tseng; Herbert J Zeh; Steven K Libutti; Gagandeep Singh; Jeffrey E Lee; Thomas A Hope; Michelle K Kim; Yusuf Menda; Thorvardur R Halfdanarson; Jennifer A Chan; Rodney F Pommier
Journal:  Pancreas       Date:  2020-01       Impact factor: 3.327

2.  ASO Visual Abstract: Surgical Treatment of Patients with Poorly Differentiated Pancreatic Neuroendocrine Carcinoma-An NCDB Analysis.

Authors:  Sarah R Kaslow; Gerardo A Vitiello; Katherine Prendergast; Leena Hani; Steven M Cohen; Christopher Wolfgang; Russell S Berman; Ann Y Lee; Camilo Correa-Gallego
Journal:  Ann Surg Oncol       Date:  2022-06       Impact factor: 5.344

3.  Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.

Authors:  Sven-Petter Haugvik; Eva Tiensuu Janson; Pia Österlund; Seppo W Langer; Ragnhild Sørum Falk; Knut Jørgen Labori; Lene Weber Vestermark; Henning Grønbæk; Ivar Prydz Gladhaug; Halfdan Sorbye
Journal:  Ann Surg Oncol       Date:  2015-12-17       Impact factor: 5.344

4.  Surgical resection of the primary tumor leads to prolonged survival in metastatic pancreatic neuroendocrine carcinoma.

Authors:  Tingting Feng; Wangxia Lv; Meiqin Yuan; Zhong Shi; Haijun Zhong; Sunbin Ling
Journal:  World J Surg Oncol       Date:  2019-03-21       Impact factor: 2.754
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.